Peter Adams, Ph.D.

Director and Professor

Cancer Types

Liver Cancer Breast Cancer Acute Myelogenous Leukemia / AML

Research Groups

C3 Single Cell Sequencing Working Group Cancer Biology and Signaling Cancer Computational Biology Cancer Epigenetics Cancer Immunology/Immunotherapy Cancer and Metabolism Cancer Prevention Cancer Stem Cells Growth Control and Genomic Stability Hematological Malignancies Mouse Models Solid Tumor Therapeutics Tumor Initiation and Maintenance Tumor Microenvironment and Metastasis

Shared Resources

In Vivo Imaging – available at MCC and SCRM Gene Transfer Targeting and Therapeutics Core Chemical Library Screening Core Functional Genomics Core Cancer Metabolism Core

Research Statement

Adams’ lab is interested in mechanisms underlying age-associated increase in cancer, particularly breast cancer and liver cancer. Adams’ lab is also discovering and development novel drug combinations to target the vulnerability of most AML based on their retention of wild type p53.